Authors: Senter, PD Beam, KS Mixan, B Wahl, AF

Citation: Pd. Senter et al., Identification and activities of human carboxylesterases for the activation of CPT-11, a clinically approved anticancer drug, BIOCONJ CHE, 12(6), 2001, pp. 1074-1080

Authors: Kanyama, H Tomita, N Yamano, T Aihara, T Miyoshi, Y Ohue, M Sekimoto, M Sakita, I Tamaki, Y Kaneda, Y Senter, PD Monden, M

Citation: H. Kanyama et al., Usefulness of repeated direct intratumoral gene transfer using hemagglutinating virus of Japan-liposome method for cytosine deaminase suicide gene therapy, CANCER RES, 61(1), 2001, pp. 14-18

Authors: Hellstrom, I Hellstrom, KE Senter, PD

Citation: I. Hellstrom et al., Development and activities of the BR96-doxorubicin immunoconjugate, METH MOL B, 166, 2001, pp. 3-16

Authors: Kerr, DE Vrudhula, VM Svensson, HP Siemers, NO Senter, PD

Citation: De. Kerr et al., Comparison of recombinant and synthetically formed monoclonal antibody-beta-lactamase conjugates for anticancer prodrug activation, BIOCONJ CHE, 10(6), 1999, pp. 1084-1089

Authors: Siemers, NO Senter, PD

Citation: No. Siemers et Pd. Senter, Selective drug delivery using targeted enzymes for prodrug activation, STUD MED C, 3, 1999, pp. 115-133

Authors: Jackson, TL Lubkin, SR Siemers, NO Kerr, DE Senter, PD Murray, JD

Citation: Tl. Jackson et al., Mathematical and experimental analysis of localization of anti-tumour antibody-enzyme conjugates, BR J CANC, 80(11), 1999, pp. 1747-1753